Recursion Pharmaceuticals Inc (RXRX)

NASDAQ · Biotechnology

4.78
+0.66 (+16.02%)
Updated Oct 6, 10:13 AM ET
AI Rating
Hold
Overall Score
62
Trend
63
Momentum
88
Risk
22

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 22, 2025 260 sessions Oct 2, 2026

AI Analysis

Recursion Pharmaceuticals Inc is trading at $4.78, up 16.02% on the session. The 50 day average sits at $3.42 and the 200 day at $3.57, which puts the stock in a downtrend. RSI is at 61.9, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $3.61 with resistance near $4.16, so that band frames the current range. Average daily movement is roughly $0.24, or about 5.0% of the share price, which is what any stop placement has to allow for. The overall health score of 62 out of 100 combines a trend score of 63, momentum of 88 and a risk score of 22.

Technical indicators

RSI (14)
61.9
strong
MACD
0.191
bullish crossover
SMA 20
3.66
SMA 50
3.42
SMA 200
3.57
downtrend
ATR (14)
0.24
avg daily range
Support
3.61
Resistance
4.16
Volume vs 20d
0.89x
below average
Volatility
85.7%
annualised
1 month
+21.89%
3 months
+4.04%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.